934993-38-1Relevant academic research and scientific papers
Synthesis of potential prodrug systems for reductive activation. Prodrugs for anti-angiogenic isoflavones and VEGF receptor tyrosine kinase inhibitory oxindoles
Blanche, Emilie A.,Maskell, Lesley,Colucci, Marie A.,Whatmore, Jacqueline L.,Moody, Christopher J.
experimental part, p. 4894 - 4903 (2009/11/30)
A number of potential prodrug systems for reductive activation have been investigated. The prodrug systems chosen for the study were the 2-nitrophenylacetyl, 3-methyl-3-(3,6-dimethyl-1,4-benzoquinon-2-yl)butanoyl and 4-nitrobenzyl groups, readily attached
